Latest Happenings

Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zone (JCI, July 2025)

Authors: Valeria Cancila, Giorgio Bertolazzi, Allison S.Y. Chan, Giovanni Medico, Giulia Bastianello, Gaia Morello, Daniel Paysan, Clemence Lai, Liang Hong, Girija Shenoy, Patrick W. Jaynes, Giovanna Schiavoni, Fabrizio Mattei, Silvia […]

Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zone (JCI, July 2025) Read More »

Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin’s Lymphoma (JCO Precision Oncology, September 2025)

Treating patients whose non-Hodgkin’s lymphoma (NHL) has come back or stopped responding to therapy remains very difficult. Many eventually run out of standard treatment options. A team led by Dr.

Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin’s Lymphoma (JCO Precision Oncology, September 2025) Read More »

CSI Singapore Collaborates with SG Code Campus, Google Cloud, IMDA, and Dunman Secondary in AI-Powered Cancer Research Education Programme for Schools

The Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore is delighted to be an academic partner in the inaugural Google Cloud AI for the Biomedical

CSI Singapore Collaborates with SG Code Campus, Google Cloud, IMDA, and Dunman Secondary in AI-Powered Cancer Research Education Programme for Schools Read More »